EFPIA Newsletter 09 March 2017

9 March 2017

News     09 March 2017 20170309 EBE, EFPIA and IFPMA have today launched a position paper entitled “Considerations... Switching describes a physician's decision to exchange one product that a patient receives for another Read more →         09 March 2017 20170309 Mutual Recognition Agreement (MRA) on Good Manufacturing Practices (GMP) heralds the... EFPIA welcomes the announcement of the adoption of an updated EU-US MRA on GMP inspections Read more →

Events calendar     17 MAY 2017   China/EU Pharmaceutical Industry Forum Shanghai, China A workshop jointly organised by EFPIA and CPIA Learn more →       28 MAR 2017   DIA BioVenture Day Glasgow, UK Is the current Bioventure paradigm delivering return for patients and investors?" is the key question to be addressed... Learn more →

	29 MAR 2017			DIA EuroMeeting 2017 Glasgow, UK DIA is the global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide... Learn more →

	01 MAY 2017			13th Annual Meeting of ISMPP - Global Publication Practices: Advancing Ethics and... National Harbor, Maryland, USA Global Publication Practices: Advancing Ethics and Scientific Integrity in an Era of Data-Sharing Learn more →

Documents Considerations for physicians on switching decisions regarding biosimilars Switching describes the medical practice of a physician deciding to exchange the product that a patient receives for another product. The practice of a physician [...] Read more

What we are reading The IMI programmes driving access to innovative medicines 09 March 2017  (Adjacent Open Access) Read more → UK children with cancer could miss out on drug trials after Brexit, doctors warn 09 March 2017  (The Guardian) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe